gptkbp:instanceOf
|
gptkb:chemical_compound
Hallucinogen
|
gptkbp:abusePotential
|
high
|
gptkbp:CASNumber
|
50559-33-8
|
gptkbp:category
|
recreational drug
psychedelic phenethylamine
|
gptkbp:chemicalFormula
|
C13H21NO3
|
gptkbp:color
|
white (as hydrochloride salt)
|
gptkbp:discoveredBy
|
gptkb:Alexander_Shulgin
|
gptkbp:drugClass
|
amphetamine
|
gptkbp:duration
|
14–20 hours
|
gptkbp:effect
|
euphoria
hallucinations
altered perception
stimulation
|
gptkbp:firstDescribed
|
gptkb:PiHKAL
|
gptkbp:hasSMILES
|
CCOC1=CC(=C(C=C1OC)CC(C)N)OC
|
https://www.w3.org/2000/01/rdf-schema#label
|
DOET
|
gptkbp:IUPACName
|
1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine
|
gptkbp:legalStatus
|
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
|
gptkbp:meltingPoint
|
unknown
|
gptkbp:molecularWeight
|
239.31 g/mol
|
gptkbp:otherName
|
2,5-dimethoxy-4-ethylamphetamine
DOEt
|
gptkbp:PubChem_CID
|
62258
|
gptkbp:relatedTo
|
gptkb:DOI
gptkb:DOM
DOB
|
gptkbp:routeOfAdministration
|
oral
|
gptkbp:solubility
|
soluble in water (as hydrochloride salt)
|
gptkbp:synthesisType
|
described in PiHKAL
|
gptkbp:toxicity
|
not well studied
|
gptkbp:UNII
|
1Q1V1K1K2E
|
gptkbp:bfsParent
|
gptkb:F.E.2a
gptkb:Alexander_Shulgin
gptkb:ALT-12
|
gptkbp:bfsLayer
|
7
|